Table 5.
GI absorption | BBB permeant | Pgp substrate | CYP1A2 inhibitor | CYP2C19 inhibitor | CYP2C9 inhibitor | CYP2D6 inhibitor | CYP3A4 inhibitor | Lipinski #violations | Bioavailability Score | PAINS #alerts | |
---|---|---|---|---|---|---|---|---|---|---|---|
5a | Low | No | No | No | Yes | Yes | Yes | Yes | 2 | 0.17 | 0 |
5b | Low | No | No | No | Yes | Yes | No | Yes | 2 | 0.17 | 0 |
5c | Low | No | No | No | Yes | Yes | Yes | Yes | 2 | 0.17 | 0 |
5d | Low | No | Yes | No | Yes | Yes | Yes | Yes | 2 | 0.17 | 0 |
5e | Low | No | No | No | Yes | Yes | Yes | Yes | 2 | 0.17 | 0 |
5f | Low | No | Yes | No | Yes | Yes | Yes | Yes | 2 | 0.17 | 0 |
6a | High | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
6b | High | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
6c | High | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
6d | Low | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
6e | High | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
6f | Low | No | No | Yes | Yes | Yes | Yes | Yes | 0 | 0.55 | 0 |
Diflapolin | Low | No | No | Yes | Yes | Yes | Yes | Yes | 1 | 0.55 | 0 |
(Continued)